IP Library Granted Patent US 9,802,914
Granted Patent B2
US 9,802,914 · App. 15/126,330 · Granted Oct 31, 2017

Antifungal compound process

Inventors: William J. Hoekstra (Durham, NC); Christopher M. Yates (Raleigh, NC)
Assignee: Viamet Pharmaceuticals, Inc.
C07D401/06A61K31/4439A61K45/06C07D213/26C07D213/30C07D213/50C07D213/61
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,802,914
App. No.
15/126,330
Granted
Oct 31, 2017
Kind
B2
Abstract

The present invention relates to a process for preparing compound 1 that is useful as an antifungal agent. In particular, the invention seeks to provide new methodology for preparing compound 1 or 1a and substituted derivatives thereof.

Claims (115)

1. A process to prepare compound 1 or 1a, or a mixture thereof; or a salt of compound 1 or 1a, or a mixture thereof:

the process comprising nitromethylating a compound of formula 15:

to provide a compound of formula 17 or 17a,

 or a mixture thereof; and

converting a compound of formula 17 or 17a,

 or a mixture thereof, to compound 1 or 1a, or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

2. The process of claim 1 comprising:

(i) reducing a comnound of formula 17 or 17a,

 or a mixture thereof, to provide a compound of formula 19 or 19a,

 or a mixture thereof;

(ii) forming the tetrazole of a compound of formula 19 or 19a,

 or a mixture thereof, to provide a compound of formula 9 or 9a,

 or a mixture thereof; and

(iii) arylating a compound of formula 9 or 9a,

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

3. A process to prepare compound 1 or 1a, or a mixture thereof; or a salt of compound 1 or 1a, or a mixture thereof:

the process comprising:

(i) arylating a compound of formula 15,

 to provide ketone

(ii) nitromethylating ketone 16,

 to provide nitro-alcohol 18 or 18a,

 or a mixture thereof;

(iii) reducing nitro-alcohol 18 or 18a,

 or a mixture thereof, to provide amino-alcohol 20 or 20a

 or a mixture thereof; and

(iv) forming the tetrazole of amino-alcohol 20 or 20a,

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

4. The process of claim 1 comprising:

(i) arylating a compound of formula 17 or 17a,

 or a mixture thereof, to provide nitro-alcohol 18 or 18a,

 or a mixture thereof;

(ii) reducing nitro-alcohol 18 or 18a,

 or a mixture thereof, to provide amino-alcohol 20 or 20a,

 or a mixture thereof; and

(iii) forming the tetrazole of amino-alcohol 20 or 20a

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

5. The process of claim 1 comprising:

(i) reducing a compound of formula 17 or 17a,

 or a mixture thereof, to provide a compound of formula 19 or 19a,

 or a mixture thereof;

(ii) arylating a compound of formula 19 or 19a,

 or a mixture thereof, to provide amino-alcohol 20 or 20a,

 and

(iii) forming the tetrazole of amino-alcohol 20 or 20a,

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl.

6. A process to prepare compound 1 or 1a, or a mixture thereof; or a salt of compound 1 or 1a, or a mixture thereof:

the process comprising:

(i) arylating a compound of formula 15,

 to provide ketone 16,

(ii) forming the cyanohydrin of ketone 16,

 to provide nitrile 24 or 24a,

 or a mixture thereof;

(iii) reducing nitrile 24 or 24a

 or a mixture thereof, to provide amino-alcohol 20 or 20a,

 or a mixture thereof; and

(iv) forming the tetrazole of amino-alcohol 20 or 20a,

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl; and

R′ is H or trimethylsilyl.

7. A process to prepare compound 1 or 1a, or a mixture thereof; or a salt of compound 1 or 1a, or a mixture thereof:

the process comprising:

cyanating a compound of formula 15,

 to provide a compound of formula 23 or 23a,

 or a mixture thereof; and

converting a compound of formula 23 or 23a,

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl; and

R′ is H or trimethylsilyl.

8. The process of claim 7 comprising:

(i) reducing a compound of formula 23 or 23a,

 or a mixture thereof, to provide a compound of formula 19 or 19a,

 or a mixture thereof;

(ii) arylating a compound of formula 19 or 19a,

 or a mixture thereof, to provide amino-alcohol 20 or 20a,

 or a mixture thereof;

(iii) forming the tetrazole of amino-alcohol 20 or 20a,

 or a mixture thereof, to provide compound 1 or 1a

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl; and

R′ is H or trimethylsilyl.

9. The process of claim 7 comprising:

(i) reducing a compound of formula 23 or 23a,

 or a mixture thereof, to provide a compound of formula 19 or 19a,

 or a mixture thereof;

(ii) forming the tetrazole of a compound of formula 19 or 19a,

 or a mixture thereof, to provide a compound of formula 9 or 9a,

 or a mixture thereof;

(iii) arylating a compound of formula 9 or 9a,

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl; and

R′ is H or trimethylsilyl.

10. The process of claim 7 , comprising:

(i) arylating a compound of formula 23 or 23a,

 or a mixture thereof, to provide nitrile 24 or 24a,

 or a mixture thereof;

(ii) reducing nitrile 24 or 24a,

 or a mixture thereof, to provide amino-alcohol 20 or 20a,

 or a mixture thereof;

(iii) forming the tetrazole of amino-alcohol 20 or 20a,

 or a mixture thereof, to provide compound 1 or 1a,

 or a mixture thereof;

wherein R is halo, —O(C═O)-alkyl, —O(C═O)-substituted alkyl, —O(C═O)-aryl, —O(C═O)-substituted aryl, —O(C═O)—O-alkyl, —O(C═O)—O-substituted alkyl, —O(C═O)—O-aryl, —O(C═O)—O-substituted aryl, —O(SO 2 )-alkyl, —O(SO 2 )-substituted alkyl, —O(SO 2 )-aryl, or —O(SO 2 )-substituted aryl; and

R′ is H or trimethylsilyl.

Assignments (3)
CHANGE OF NAME Recorded Mar 28, 2018
From: VIAMET PHARMACEUTICALS (NC), INC.
To: MYCOVIA PHARMACEUTICALS, INC.
Reel/Frame 045759/0728 →
CHANGE OF NAME Recorded Jan 2, 2018
From: VIAMET PHARMACEUTICALS, INC.
To: VIAMET PHARMACEUTICALS (NC), INC.
Reel/Frame 044978/0893 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 12, 2016
From: HOEKSTRA, WILLIAM J.; YATES, CHRISTOPHER M.
To: VIAMET PHARMACEUTICALS, INC.
Reel/Frame 039999/0291 →
Continuity (2)
Provisional Application 61955554 · Mar 19, 2014
Related Publication 20170081309A1 · Mar 23, 2017